Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 3

Sponsor Class

OTHER 16NIH 3

Study Type

Observational 2Interventional 1

Sponsor

Cancer Type

Breast 2Gynecologic 1

Conditions

Breast Neoplasms 309Neoplasms 269Prostatic Neoplasms 189Precursor Cell Lymphoblastic Leukemia-Lymphoma 186Lymphoma 184Leukemia, Lymphocytic, Chronic, B-Cell 161Melanoma 158Leukemia 154Lymphoma, Non-Hodgkin 149Leukemia, Myeloid, Acute 149Brain Neoplasms 143Carcinoma, Non-Small-Cell Lung 141Lymphoma, Large B-Cell, Diffuse 128Colonic Neoplasms 128Lymphoma, Follicular 123Burkitt Lymphoma 119Ovarian Neoplasms 117Lung Neoplasms 116Glioblastoma 116Lymphoma, Mantle-Cell 114Unspecified Adult Solid Tumor, Protocol Specific 107Rectal Neoplasms 103Sarcoma 102Multiple Myeloma 102Gliosarcoma 102Hodgkin Disease 97Carcinoma, Renal Cell 97Lymphoma, B-Cell, Marginal Zone 96Astrocytoma 95Carcinoma, Ovarian Epithelial 93

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × NIH × Risk Reduction Behavior × Clear all
NCT00040222 2026-06-01

Clinical, Genetic, Behavioral, Laboratory and Epidemiologic Characterization of Individuals and Families at High Risk of Breast/Ovarian Cancer

National Institutes of Health Clinical Center (CC)

Completed
377 enrolled
BreastGynecologic

Breast Cancer, Familial, Breast Neoplasms, Hamartoma Syndrome, Multiple, Ovarian Neoplasms, Peutz-Jeghers Syndrome, Li-Fraumeni Syndrome, Risk Reduction Behavior

NCT02317367 2021-08-30

Self-Affirmation: Construct Validity

National Institutes of Health Clinical Center (CC)

Completed
3,112 enrolled
Breast

Alcohol Drinking, Breast Neoplasms, Risk Reduction Behavior

NCT00906321 2017-07-02

Facilitating Web-based Patient Decision Support: Decision About Medication to Lower Breast Cancer Risk

National Institutes of Health Clinical Center (CC)

Phase NA Completed
64 enrolled

Risk Reduction Behavior

Data powered by HemOnc (CC BY 4.0) Colophon âš¡